metyrapone has been researched along with Anti-MuSK Myasthenia Gravis in 4 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KLEIN, JJ | 1 |
| OSSERMAN, KE | 1 |
| Grob, D | 1 |
| Namba, T | 1 |
| Cape, CA | 2 |
| Arbona, NJ | 2 |
| Patterson, SM | 1 |
4 other studies available for metyrapone and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
STUDIES IN MYASTHENIA GRAVIS. PITUITARY-ADRENAL FUNCTION.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Biomedical Re | 1964 |
Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses.
Topics: Adrenocorticotropic Hormone; Adult; Female; Humans; Injections, Intramuscular; Injections, Intraveno | 1966 |
Correlation of the clinical response to ACTH treatment with the endocrine status in myasthenia gravis.
Topics: Adrenocorticotropic Hormone; Dexamethasone; Eye Diseases; Humans; Metyrapone; Myasthenia Gravis; Pit | 1973 |
Endogenous ACTH induced remission in myasthenia gravis.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Dexamethasone; Humans; Male; Metyrapone; Middle Aged; M | 1973 |